Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam versus dexmedetomidine for sedation before intubation in poisoned ICU patients
IRCT20211022052838N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Intoxication comparing Dexmedetomidine arm with Midazolam arm (2 arms). Primary endpoints: Sedation rate assessed by RASS, Blood pressure and 1 more. Started Jun 2023; status: completed.
02
Drugs
dexmedetomidinemidazolam
03
Conditions
Intoxication
Beyond the preview
Go deeper on IRCT20211022052838N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211022052838N1.